Leap Investments’s Insmed INSM Stock Holding History

Leap Investments’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,300	Closed	-$197K	–	480
2020 Q1	$197K	Buy	+12,300	New	+$292K	0.29%	156
2019 Q3	–	Sell	-9,000	Closed	-$230K	–	442
2019 Q2	$230K	Buy	+9,000	New	+$251K	0.31%	133

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Leap Investments's INSM Position: Q2 2020 in Review

Leap Investments sold out of Insmed (INSM) in Q2 2020, closing a stake of 12,300 shares — an estimated $197K sold.

Leap Investments first reported a position in INSM in Q2 2019 and held it in 2 quarters. The position peaked at $230K in Q2 2019. 191 funds tracked by Wall St. Rank hold INSM as of Q2 2020.

Leap Investments reported no remaining Insmed position as of Q2 2020 after selling out during the quarter.
Leap Investments sold 12,300 Insmed shares in Q2 2020, an estimated $197K.
Leap Investments first reported a position in Insmed in Q2 2019 and held it in 2 quarters.
Leap Investments's Insmed position peaked at $230K in Q2 2019.
191 funds tracked by Wall St. Rank held Insmed as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.